The global biologics research and development arm of AstraZeneca will contribute both funding and a post-doctoral scientist to work within the laboratory of Kevin Brindle in the area of tumour targeted therapies. Read the full story on the main University news web site.
you use our web site. We may also use external analysis systems which may
set additional cookies to perform their analysis.These cookies (and any
others in use) are detailed in our site privacy and cookie policies and are
integral to our web site. You can delete or disable these cookies in your
web browser if you wish but then our site may not work correctly.